Business · 20/02/2020
FDA Reopens Comment Period for Draft Guidance on Compounding Animal Drugs
The US Food and Drug Administration (FDA) is reopening the comment period for its draft guidance on compounding animal drugs from bulk drug substances, allowing industry stakeholders to update their comments and submit new information.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →